quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 25, 2026

AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz

View original at finance.yahoo.com
AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Exa Labs usage has grown to more than 5,000 businesses since pivoting to an API-first model in early 2023.

    60% confidence
  • Exa Labs will use new capital to train its next generation of models and expand infrastructure capable of handling hundreds of thousands of searches per second.

    60% confidence
  • Exa's search tools are used by more than 400,000 developers.

    60% confidence
  • Competitors built on top of existing search engines will struggle to match Exa's combination of speed, cost efficiency, and retrieval quality.

    60% confidence
  • Building a perfect search engine will be extremely hard. It is also necessary. Information is critical civilizational infrastructure for our new AI reality. If we can build perfect search so that every AI has the highest quality information, then every human will too.

    60% confidence
  • AI-driven search demand will surge as more autonomous agents come online.

    60% confidence
  • Exa's crawlers index more than 500 billion URLs and the company has developed its own vector database to support high query volumes.

    60% confidence
  • Different AI agents require different retrieval behavior — from go-to-market tools needing broad coverage of people and organizations, to coding assistants relying on precise results from repositories and technical documentation.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz — Source | Via News | pt.VIA.NEWS